Dermatofibrosarcoma protuberans
Exam relevance: in 4 of more than 50 board exam reports · rank 33
- Synonyms
- DFSP
- Specialty
- Dermatology · Skin tumours
- Images
- Clinical 1 · Histology 2
- In the app
- 8 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)

Histology
HistologyDefinition
Definition & Epidemiology
- Most common sarcoma of the skin, fibroblastic differentiation with (myo-)fibroblastic components.
- Average age: ~ 40 years, slow destructive local growth.
- Metastasis is rare – figures differ: Braun-Falco (2018, p. 1896) gives under 5 % (regional lymph nodes and lung), DermNet NZ about 5 % (roughly 1 % lymphatic, 4 % haematogenous, most often to the lung). A systematic review found metastases in 1.1 % of classic DFSP but in 14.4 % of tumours with fibrosarcomatous transformation (Liang et al. 2014); Braun-Falco likewise gives 15 % for dedifferentiated variants.
Classification
Sub-Variants
- Classic DFSP — as above.
- Bednar tumor (pigmented DFSP variant): melanin-containing dendritic cells.
- Fibrosarcomatous DFSP transformation (DFSP-FS): Dedifferentiation + Mitosis ↑.
- Giant cell fibroblastoma: pediatric variant, same COL1A1-PDGFB translocation.
Clinical features
Clinical Presentation
- Location: trunk-predominant (~ 50 %), proximal extremities, shoulders; rarely head and neck.
- Appearance: brownish-livid plaque.
- Course: Years of unremarkable plaque-stage progression until nodular manifestation; destructive-infiltrative, R0 resection technically challenging due to tentacular subcutaneous extensions.
Diagnosis
Diagnostics
- Clinical presentation + ultrasound of the primary tumor (depth of extension, hypoechoic-heterogeneous).
- MRI in case of suspected deep infiltration (subcutis, fascia).
- Immunohistochemistry: CD34+, F XIIIa− for differentiation from dermatofibroma (= XIIIa+).
- Molecular: FISH or RT-PCR for COL1A1-PDGFB fusion to confirm difficult cases (e.g., fibrosarcomatous variant).
- Staging: Whole-body examination + ultrasound of regional lymph nodes; cross-sectional imaging (CT/MRI) for DFSP-FS, very extensive tumours, local recurrence or suspected metastases.
Differential diagnoses
Dermatofibroma
Lipoma
Epidermal cyst (atheroma)
Basal cell carcinoma
Melanoma
Kaposi's sarcoma
Cutaneous angiosarcoma
Image credits for the thumbnails
- Dermatofibroma: Jmarchn, “Pigmented and tenderness dermatofibroma”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Lipoma: James Heilman, MD, “LipomaBack”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Epidermal cyst (atheroma): unknown (Commons user), “Epidermal Cyst ear”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Basal cell carcinoma: Bin im Garten, “Basaliom am Nasenrücken 2”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Melanoma: National Cancer Institute (unknown photographer), “Melanoma (4)”, Public Domain, via Wikimedia Commons · Public domain · Source
- Kaposi's sarcoma: unknown author, “Kaposi's Sarcoma”, Public Domain, via Wikimedia Commons · Public Domain · Source
- Cutaneous angiosarcoma: Messias H, Martins M, Zagalo C et al. (Cancer Rep (Hoboken) 2022), CC BY 4.0, via PubMed Central (PMC9575495) · CC BY 4.0 · Source
Treatment principles
- The treatment of choice is micrographically controlled surgery including the fascia; if this is not available, wide local excision is performed.
- Radiotherapy is an option for primarily inoperable tumours, for residual tumour when re-excision is not possible and after multiple recurrences; after complete removal no adjuvant irradiation is given.
- Locally advanced, inoperable or metastatic tumours can be treated with a tyrosine kinase inhibitor; because late recurrences occur, long-term follow-up is required.
Guideline: AWMF guideline register (no. 032-026)
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Mentioned in
Keep learning: test yourself
Two questions from the DermaFuchs app on Dermatofibrosarcoma protuberans – tap an answer.
Question 1 of 2
What is the immunohistochemical profile of dermatofibrosarcoma protuberans (DFSP)?
Answer
Correct: CD34+, CD99+, Factor XIIIa−. DFSP typically shows positivity for CD34 and CD99, and negativity for Factor XIIIa, aiding in its diagnosis.
Question 2 of 2
What is the typical appearance of Dermatofibrosarcoma protuberans?
Answer
Correct: brownish-livid plaque. Dermatofibrosarcoma protuberans typically appears as a brownish-livid plaque.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.